Original Research
Accepted on 02 Dec 2024
VASN knockout induced myocardial fibrosis by downregulating non collagen fibers and promoting inflammation in mice
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1500617
Type at least 3 characters
1,650 articles
Articles
Correction
Accepted on 02 Dec 2024
Apolipoprotein A-I attenuates peritoneal fibrosis associated with peritoneal dialysis by inhibiting oxidative stress and inflammation
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1532774
Original Research
Published on 26 Nov 2024
A sulfonimide derivative of bezafibrate as a dual inhibitor of cyclooxygenase-2 and PPARα
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1488722
- 284 views
Review
Accepted on 25 Nov 2024
The Advent of Chimeric Antigen Receptor T Cell Therapy in Recalibrating Immune balance for Rheumatic Autoimmune Disease Treatment
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1502298
Review
Accepted on 22 Nov 2024
Decoding Ferroptosis: Transforming Orthopedic Disease Management
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1509172
Original Research
Published on 21 Nov 2024
Polyvinylalcohol-carbazate mitigates acute lung injury caused by hydrochloric acid
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1503648
- 137 views
Editorial
Accepted on 18 Nov 2024
Editorial on the Research Topic: Recent Advances in the Pathogenesis and Potential Biomarkers of Fibrosis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1527123
Review
Accepted on 12 Nov 2024
New insights into SUMOylation and NEDDylation in fibrosis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1476699
Correction
Published on 08 Nov 2024
Corrigendum: Efficacy of hyaluronic acid in the treatment of nasal inflammatory diseases: a systematic review and meta-analysis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1404434
- 189 views
Review
Published on 07 Nov 2024
Estrogen: the forgotten player in metaflammation
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1478819
- 731 views
Review
Published on 06 Nov 2024
P4HA1: an important target for treating fibrosis related diseases and cancer
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1493420
- 449 views
Review
Published on 05 Nov 2024
The impact of diabetes mellitus on tendon pathology: a review
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1491633
- 362 views
Editorial
Published on 31 Oct 2024
Editorial: Chronic pain: what is the mechanism?
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1496510
- 282 views
Case Report
Published on 30 Oct 2024
Mycophenolate mofetil after tacrolimus for refractory clinically amyopathic dermatomyositis: a case report
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1472667
- 491 views
Review
Published on 29 Oct 2024
JAK inhibitors: an evidence-based choice of the most appropriate molecule
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1494901
- 569 views
Editorial
Published on 28 Oct 2024
Editorial: Epigenetics of inflammatory reactions and pharmacological modulation
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1505196
- 194 views